CIA - Collegium Internationionale Allergologicum

28th symposia header
 


Abstract Submission

Abstract submission is now closed

Word Limit: 350 words

The Collegium Internationale Allergologicum invites members and non-members to submit abstracts for review for poster or oral presentation at the 28th Symposium in Ischia.

The following guidelines address key factors that the Collegium Internationale Allergologicum Organizing Committee considers when reviewing abstracts. Attention to these details will assist the Committee in making their decision.

  • Abstracts should contain a concise statement of the problem under investigation; describe experimental methods used; contain specific findings and data (promises such as "the results to be completed" are not appropriate); and contain conclusions based on the data presented (statistical analyses should be used when appropriate to support the conclusions).
  • Define all concepts and abbreviations at first use. Do not use abbreviations in the title of the abstract.
  • Previously published abstracts will NOT be considered.
  • All abstract presenters will be required to register for the symposium, and pay all registration and travel costs.
  • Abstract submissions can only be made by Collegium Internationale Allergologicum members, candidates or sponsored non-members.

Abstracts can be submitted in the following categories:

Category 1: Genetic and environmental factors in allergic disorders

  • Genetics of allergic disorders
  • Environmental factors in immune disorders
  • Epidemiology: risk and protective factors in allergy

Category 2: Dendritic cells, mast cells, monocytes and granulocytes

  • Dendritic cells
  • Monocytes/Macrophages
  • Mast cells and basophils
  • Eosinophils and neutrophils

Category 3: Lymphocytes and mediators of immunoregulation

  • Cytokines
  • Chemokines
  • T-Cells and Regulatory T-cells
  • NK and iNKT cells
  • Immunoregulation
  • Adjuvants

Category 4: Conventional and novel biomarkers of asthma and COPD

  • Proinflammatory biomarkers
  • Angiogenic mediators

Category 5: Clinical aspects of allergic disorders

  • Asthma and anaphylaxis
  • Rhinitis
  • Atopic Dermatitis
  • Food allergy and gastrointestinal inflammatory conditions

Category 6: Urticaria and angioedema

  • Pharmacological therapies
  • Novel biological therapies

Category 7: Allergens and diagnosis of allergy

  • Allergens
  • Triggers of allergy
  • Biomarkers of allergy: prognosis, severity and treatment efficacy
  • Diagnostic methodologies

Category 8: Pathophysiology of allergic disorders and inflammation

  • Animal models of allergy
  • Mediators of inflammation
  • Immunoglobulins: roles, receptors, regulation
  • Pathophysiology of the allergic response
  • Inflammation: acute/chronic

Category 9: Treatment of immune disorders

  • Immunomodulation: strategies for prevention and treatment
  • Allergic diseases
  • Autoimmune diseases
  • Immunodeficiencies
  • Experimental therapeutics

Category 10: Allergen specific immunotherapy

  • SLIT
  • SCIT
  • Novel therapies